A Phase I/ii Study Of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumour
Children and young adults with gastrointestinal stromal tumours (GIST) will be treated with
sunitinib. The safety (including pharmacokinetics) and tolerability of sunitinib will be
studied in these patients. In addition, tumour responses and overall survival will be
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society